Zogenix Acquires U.K.|Based Brabant Pharma

Zogenix Acquires U.K.-Based Brabant Pharma | Fierce Biotech

SAN DIEGO, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. ... The acquisition includes worldwide development and commercialization rights ...

Zogenix Acquires Brabant Pharma in Up to $130M Deal

Zogenix, a pharmaceutical company focused on the treatment of pain-related and central nervous system disorders, acquired Brabant Pharma for $20 million in ...

Zogenix Acquires Brabant Pharma in $35M Deal - ProQuest

... acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company for $20 million in cash and $15 million in stock, plus potential future ...

Zogenix Acquires U.K.-Based Brabant Pharma - GlobeNewswire

The study is continuing today with fenfluramine sourced by Brabant Pharma, manufactured from a synthetic process consistent with current ...

Zogenix acquires U.K.-based Brabant Pharma | Drug Discovery News

Zogenix acquires U.K.-based Brabant Pharma. Obtains global rights for treatment option in development for Dravet syndrome, a rare and catastrophic form of ...

Zogenix Inc. has acquired Brabant Pharma - Global M&A Partners

Zogenix Inc. USA Based - Pharmaceutical Company Zogenix Acquires UK Bases Brabant Pharma for up to $130m. logo. Advisor : Zeus ...

Form 8-K - SEC.gov

On October 24, 2014, Zogenix Europe completed its acquisition of Brabant as described in Item 1.01, which description is incorporated herein by ...

Zogenix Acquires Brabant Pharma Drug Lead For Dravet Syndrome

Pharmaceutical company Zogenix announced that it has acquired U.K.-based Brabant Pharma along with global rights to Brabafen...

Zogenix acquires UK-based Brabant Pharma for up to $130 million

Zogenix acquires UK-based Brabant Pharma for up to $130 million.

Zogenix Acquires Brabant Pharma in $35M Deal - San Diego ...

Zogenix Acquires Brabant Pharma in $35M Deal ... The acquisition includes worldwide development and commercialization rights to Brabafen, a treatment for Dravet ...

EX-10.1 - SEC.gov

(2) ZOGENIX, INC. (3) ZOGENIX EUROPE LIMITED. and. (4) BRABANT PHARMA LIMITED. AGREEMENT. for sale and purchase of. BRABANT ...

Zogenix acquires Brabant pharma - 2014-10-27 - Crunchbase

Brabant pharma Brabant Pharma is in late-stage development of a treatment for Dravet Syndrome. Acquiring Organization: Zogenix Logo. Zogenix Zogenix develops ...

Zogenix, Inc. - Annual Reports

In October 2014, Zogenix Europe Limited, our wholly-owned subsidiary, acquired Brabant Pharma Limited, or Brabant, a privately-held company organized under ...

UCB to acquire Zogenix

... company's proposed acquisition of Zogenix. Such forward-looking ... These statements are based on Zogenix's current beliefs and expectations.

Brabant Pharma, Zogenix deal - BioCentury

In late October, Zogenix acquired Brabant for $20 million in cash and $15 million in stock, plus up to $50 million in regulatory milestone ...

Brabant pharma - Crunchbase Company Profile & Funding

Based on the incidence of Dravet Syndrome, the new treatment will ... Brabant pharma acquired by Zogenix Logo. Brabant pharma acquired by Zogenix.

Zogenix delays epilepsy drug trials by three months - Yahoo Finance

Zogenix acquired ZX008 when it bought U.K.-based private company Brabant Pharma in October 2014. The treatment currently has orphan drug status in the United ...

Aquarius sells Brabant for $35m - Unquote

Aquarius Equity Partners has sold Brabant Pharma, a UK biotech ... pharma company Zogenix for a total consideration of $35m. The sale ...

ZOGENIX INC. - Annual Reports

an acquisition of Brabant Pharma, a privately-held U.K.-based pharmaceutical company. In March 2019, we entered into an exclusive.

Dr. Stephen Farr Appointed As CEO Of Zogenix (ZGNX) To Lead ...

... acquisition of Brabant Pharma. The transformational acquisition of ... These statements are based on the company's current beliefs and ...